Imaging Features, Staging System, and Surgical Management of Giant Cell Lesions of the Temporal Bone.

Xiaohong Li,Yi Wen,Jie Zhang,Nan Wu,Weidong Shen,Shiming Yang,Pu Dai,Dongyi Han,Yang,Weiju Han,Bo Feng,Guojian Wang
DOI: https://doi.org/10.1080/00016489.2022.2099969
IF: 1.698
2022-01-01
Acta Oto-Laryngologica
Abstract:BACKGROUND:Giant cell tumors (GCTs) and giant cell granulomas (GCGs) are giant cell-rich lesions that occur extremely rarely in the temporal bone and have similar clinical presentations.OBJECTIVES:We aimed to analyze the clinical features and introduce our staging system and surgical treatment.METHODS:Forty-six patients pathologically diagnosed with a giant cell lesion involving the temporal bone between October 2001 and October 2020 were reviewed retrospectively. The clinical characteristics, surgical approaches, and risk factors for recurrence were analyzed.RESULTS:GCTs and GCGs presented as masses centered on the temporomandibular joint with similar imaging features, including a thin, calcified shell and central scattered calcifications on a computed tomography scan. Differences were detected on magnetic resonance imaging in 29.6% (4/14) of GCG and 50% (16/32) of GCT cases; the remaining cases were not distinguishable. Based on our staging system and surgical strategy, 31.8% (7/22) of GCT and 10% (1/10) of GCG cases experienced recurrence, which compares to recurrence rates of 60% in GCT cases and 20% in GCG cases in previous studies.CONCLUSIONS:Specific clinical and preoperative imaging features help to make a diagnosis of temporal giant cell-rich lesions. Our staging system and surgical strategy could help surgeons tailor the surgical strategy.
What problem does this paper attempt to address?